Clinical Trials
2 trialsNCT03580239 2018-07-09
Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency
Tianjin Medical University Second Hospital
Phase 3 Unknown
NCT00657982 2009-01-21
Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer
Sheba Medical Center
Phase 2 Unknown